The long term goal of this research is to determine what factors regulate expression of the glucocorticoid receptor (GR) protein, how this causes hormone-mediated apoptosis in leukemic cells, and how new targeted, rational, chemotherapeutic modalities can be developed to treat T-cell acute lymphoblastic leukemia (ALL). The central hypothesis of this research proposal is that regulated and selective GR promoter utilization is important in physiological and pathological conditions, and that this can be exploited in developing treatment modalities in the future.
The specific aims of this proposal are to: 1) analyze the cell cycle (S phase) specific regulation of GR gene expression including the: role that the transcription factor YY1 plays in regulating GR gene transcription; possible involvement of nuclear matrix association in this process; identification of the GR promoter sequences that regulate cell cycle dependent expression; 2) resolve the contribution of differential GR promoter utilization in cell type-and cell cycle- dependent expression of the GR gene, focusing on the: possible role for matrix localization of the promoter sites; cis-acting and trans-acting factors that control preferential GR promoter utilization; and 3) determine the mechanism for coordinate up-regulation of GR and c-jun gene expression in T-cell ALL, which is responsible for glucocorticoid- mediated apoptosis, by: mapping the element(s) in the c-jun promoter responsible for hormone-induced activation; isolating the human T-cell specific GR promoter and identifying the GR promoter element(s) that are activated by hormone. These comprehensive, yet focused, studies will give definitive answers about three important, yet poorly understood, aspects of GR action: the cell-cycle specific expression of the GR; selective GR receptor promoter utilization; and, the mechanism by which GR up-regulation during hormone treatment induces apoptosis in T-cell lymphoblasts. Future extensions of this research will be to determine if promoter silencing plays a role in the conversion of T-lymphoblasts from the steroid-sensitive to the hormone-resistant phenotype. An eventual goal will be to analyze GR promoter utilization and structure in glucocorticoid-resistant, human T-lymphoblasts from acute lymphoblastic leukemia patients at diagnosis, during remission, and at relapse. Ultimately, we wish to translate these basic science results into clinical applications regarding a rationale approach to combined chemotherapy in T-cell ALL.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK047211-07
Application #
6380835
Study Section
Endocrinology Study Section (END)
Program Officer
Margolis, Ronald N
Project Start
1994-08-01
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
7
Fiscal Year
2001
Total Cost
$180,596
Indirect Cost
Name
Louisiana State University Hsc New Orleans
Department
Biochemistry
Type
Schools of Medicine
DUNS #
782627814
City
New Orleans
State
LA
Country
United States
Zip Code
70112
Nunez, B Scott; Geng, Chuan-Dong; Pedersen, Kim Brint et al. (2005) Interaction between the interferon signaling pathway and the human glucocorticoid receptor gene 1A promoter. Endocrinology 146:1449-57
Geng, Chuan-dong; Pedersen, Kim Brint; Nunez, B Scott et al. (2005) Human glucocorticoid receptor alpha transcript splice variants with exon 2 deletions: evidence for tissue- and cell type-specific functions. Biochemistry 44:7395-405
Pedersen, Kim Brint; Geng, Chuan-dong; Vedeckis, Wayne V (2004) Three mechanisms are involved in glucocorticoid receptor autoregulation in a human T-lymphoblast cell line. Biochemistry 43:10851-8
Geng, Chuan-Dong; Vedeckis, Wayne V (2004) Steroid-responsive sequences in the human glucocorticoid receptor gene 1A promoter. Mol Endocrinol 18:912-24
Pedersen, Kim Brint; Vedeckis, Wayne V (2003) Quantification and glucocorticoid regulation of glucocorticoid receptor transcripts in two human leukemic cell lines. Biochemistry 42:10978-90
Nunez, B Scott; Vedeckis, Wayne V (2002) Characterization of promoter 1B in the human glucocorticoid receptor gene. Mol Cell Endocrinol 189:191-9
Breslin, M B; Geng, C D; Vedeckis, W V (2001) Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids. Mol Endocrinol 15:1381-95
Wagner, B L; Pollio, G; Giangrande, P et al. (1999) The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestins. Endocrinology 140:1449-58
Breslin, M B; Vedeckis, W V (1998) The human glucocorticoid receptor promoter upstream sequences contain binding sites for the ubiquitous transcription factor, Yin Yang 1. J Steroid Biochem Mol Biol 67:369-81
Wei, P; Inamdar, N; Vedeckis, W V (1998) Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter. Mol Endocrinol 12:1322-33

Showing the most recent 10 out of 15 publications